- Home
- TMDX vs CRTO Comparison
TMDX vs CRTO Comparison
Compare TMDX & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- CRTO
- Stock Information
- Founded
- TMDX 1998
- CRTO 2005
- Country
- TMDX United States
- CRTO France
- Employees
- TMDX N/A
- CRTO N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRTO Advertising
- Sector
- TMDX Health Care
- CRTO Consumer Discretionary
- Exchange
- TMDX Nasdaq
- CRTO Nasdaq
- Market Cap
- TMDX 2.3B
- CRTO 2.1B
- IPO Year
- TMDX 2019
- CRTO 2013
- Fundamental
- Price
- TMDX $68.58
- CRTO $35.02
- Analyst Decision
- TMDX Buy
- CRTO Buy
- Analyst Count
- TMDX 10
- CRTO 10
- Target Price
- TMDX $118.44
- CRTO $54.67
- AVG Volume (30 Days)
- TMDX 929.2K
- CRTO 331.9K
- Earning Date
- TMDX 04-29-2025
- CRTO 05-01-2025
- Dividend Yield
- TMDX N/A
- CRTO N/A
- EPS Growth
- TMDX N/A
- CRTO 115.91
- EPS
- TMDX 1.01
- CRTO 1.90
- Revenue
- TMDX $441,540,000.00
- CRTO $1,933,289,000.00
- Revenue This Year
- TMDX $25.24
- CRTO N/A
- Revenue Next Year
- TMDX $19.89
- CRTO $7.82
- P/E Ratio
- TMDX $67.90
- CRTO $19.28
- Revenue Growth
- TMDX 82.74
- CRTO N/A
- 52 Week Low
- TMDX $55.00
- CRTO $33.15
- 52 Week High
- TMDX $177.37
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- TMDX 47.95
- CRTO 38.19
- Support Level
- TMDX $66.69
- CRTO $34.53
- Resistance Level
- TMDX $73.68
- CRTO $38.48
- Average True Range (ATR)
- TMDX 3.42
- CRTO 1.42
- MACD
- TMDX 0.17
- CRTO 0.16
- Stochastic Oscillator
- TMDX 53.89
- CRTO 17.70
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.